ErSO
ErSO is a selective anticipatory unfolded protein response (a-UPR) activator. ErSO acts through ERα to elicit strong and sustained cytotoxic activation of the a-UPR. ErSO can be used for the research of cancer[1].
Product Specifications
CAS Number
[2407860-35-7]
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/erso.html
Purity
99.95
Solubility
DMSO : 120 mg/mL (ultrasonic)
Smiles
O=C1NC2=C(C=CC=C2C(F)(F)F)[C@@]1(C3=CC=C(O)C=C3)C4=CC=C(OC(F)(F)F)C=C4
Molecular Formula
C22H13F6NO3
Molecular Weight
453.33
References & Citations
[1]Boudreau MW, et al. A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice. Sci Transl Med. 2021;13 (603) :eabf1383.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15231188 1 Vial
Lentiviral mouse Hsph1 shRNA (UAS) - Lentiviral mouseHsph1 shRNA (UAS, GFP) (25)
Ask
View Details MBS6187480-01 0.1 mL
GZMA (Granzyme A (Granzyme 1, Cytotoxic T-Lymphocyte-Associated Serine Esterase 3), CTLA3, HFSP) (PE)
Ask
View Details MBS6187480-02 5x 0.1 mL
GZMA (Granzyme A (Granzyme 1, Cytotoxic T-Lymphocyte-Associated Serine Esterase 3), CTLA3, HFSP) (PE)
Ask
View Details 